| Ticker Symbol: | ELN |
|---|---|
| Exchange: | NYSE |
| Contact Info: | |
| CEO/President: | |
| Industry: | Medical - Drugs / Standard Industry Code: 2834 |
| Description: | Elan Corporation, plc is a leading worldwide specialty pharmaceutical company focused on the discovery, development and marketing of therapeutic products and services in neurology, acute care and pain management and on the development and commercialization of products using its extensive range of proprietary drug delivery technologies. The company consists of three operating divisions: Elan Pharmaceuticals, Elan Pharmaceutical Technologies and Elan Pharmaceutical Operations. |
| Shares Outstanding: | 470,200 (000) | Market Value: | 3,155,010 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 59.98% | Number of Inst.Shareholders: | 1.40% |
| Last Quarter Sales: | 270.10 ($Mil.) | Last Quarter Net Income: | -83.50 ($Mil.) |
| Last Quarter EPS: | -0.18 | P/E Ratio: | 0 |
| Most Recent Earnings: | -0.18 on 10/23/08 | Earnings Per Share: | -0.69 |
| Most Recent Split: | 2-1 on 06/07/99 | Annual Dividend Rate: | 0 |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |

| PFIZER INC | -28.40 | 15.92 | |
| JOHNSON AND JOH | -13.30 | 59.27 | |
| BRISTOL MYERS S | -24.10 | 19.70 | |
| SCHERING PLOUGH | -43.90 | 15.18 | |
| MERCK CO INC | -55.10 | 25.99 |
